Supporting Trials
We work in partnership with a range of organisations on large scale multi-centre clinical trials. Discover some of the projects we're currently collaborating on.
Supporting trials
| Trial name | Description | Collaborator | Status |
| A trial looking at bevacizumab after surgery for melanoma skin cancer |
Cancer Research UK | Results | |
| COPERS | Can we identify how programmes aimed at promoting self management in musculoskeletal pain work and who benefits? A systematic review of sub-group analysis within RCTs. | Barts and the London School of Medicine and Dentistry | Completed |
| A trial looking at docetaxel chemotherapy for advanced cancer of the stomach, the oesophagus or the junction of the stomach and oesophagus | Cancer Research UK | Results | |
| A trial looking at using a dye during surgery for mouth and throat cancer. | Cancer Research UK |
Closed |
|
| LIPOS | Liraglutide in PCOS (LIPOS) Study: Evaluation of the Efficacy of Liraglutide on Menstrual Cyclicity in Women with PCOS - a prospective randomised double-blind placebo-controlled study | Reproductive health | Closed |
| A trial looking at chemotherapy before and after surgery for advanced peritoneal cancer |
Cancer Research UK | Results | |
| A trial looking at chemotherapy before surgery for breast cancer | Cancer Research UK | Results | |
| OSCAR | The trial is comparing conventional positive pressure ventilationwith high frequency oscillatory ventilation (HFOV) for adults with acute respiratory distress syndrome. | University of Oxford | Completed |
| A study looking at why people respond differently to the same chemotherapy | Cancer Research UK | Closed | |
| TANDEM |
Investigating whether a cognitive behavioural approach (CBA) intervention, delivered prior to PR can help to improve mild to moderate anxiety and/or depression in those with moderate to very severe COPD and consequently encourage PR uptake/completion. |
Queen Mary University of London | Follow-up |
| VICTOR | The trial鈥檚 aim was to answer the question of whether VIOXX庐, a potent orally active COX-2 inhibitor licensed for use in osteoarthritis, has a role as maintenance therapy in colorectal cancer patients following potentially curative therapy. | University of Oxford | Completed |
| Exploring a research framework that can provide meaningful data regarding the clinical and cost effectiveness of treatments of fracture of the proximal femur | University of Oxford |